News

troubled by ethical dilemma decision

Almost two in five physicians suffered moral distress in the two weeks leading up to their being asked about it by researchers. That was a markedly larger slice than the team observed in the general U.S. working population. 

Cryoablation treatment for inoperable non-small cell lung cancer

New findings suggest that the procedure offers effective local control and a favorable safety profile for patients with medically inoperable stage 1A non-small cell lung cancer.

Thumbnail

Gadolinium-153, or Gd-153, is routinely used to calibrate nuclear imaging equipment. It has been in short supply since 2023 when global distribution of the radioisotope came to a halt. 

intrasaccular flow disruptor coronary aneurysm

A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.

Radiologist Michael Morris, MD, radiologist and director of cardiac CT and MRI at Banner Health, explains how cardiac radiology imaging is moving toward expanded use of fractional flow reserve CT (FFR-CT) and artificial intelligence analysis of coronary CT angiography (CCTA) exams as a standard of care. He spoke to Radiology Business during RSNA 2025.

The specialty is moving toward expanded use of fractional flow reserve CT and AI analysis of coronary CT angiography exams as a standard of care.

The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities. 

Xiaodong Zhang, MD, PhD,

The first FDA-approved pacing lead specifically developed for LBBAP is now being implanted throughout the United States. 

Guerbet

Regulators recently scolded the France-based pharmaceutical firm for safety issues that occurred at its plant in Raleigh, North Carolina, which produces imaging contrast agents. 

artificial intelligence AI in healthcare

When patients without diabetes land in the hospital after a heart attack or stroke, early treatment with tirzepatide may prove beneficial. 

Workflow efficiencies and automation enhance newer cardiovascular IT systems

Bringing in a new and improved cardiovascular IT system can save physicians a ton of time and lead to considerable cost savings.

overweight patient seeking health advice

Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals. 

cvb forty under 40 teaser

The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40. 

Around the web

Almost two in five physicians suffered moral distress in the two weeks leading up to their being asked about it by researchers. That was a markedly larger slice than the team observed in the general U.S. working population.